Sale

Stretch Marks Treatment Market

Global Stretch Marks Treatment Market Size, Analysis, Forecast: By Treatment Type: Topical Products, Lasers, Microdermabrasion, Others; By Route of Administration: Oral, Topical, Others; By End User: Hospitals, Specialty Clinics, Homecare, Others; By Treatment Channel; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Stretch Marks Treatment Market Outlook

The global stretch marks treatment market size was valued at USD 2.66 billion in 2023, driven by the heightened prevalence of obesity. The market is anticipated to grow at a CAGR of 8.3% during the forecast period of 2024-2032 to achieve a value of USD 5.46 billion by 2032.

 

Global Stretch Marks Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Demand for Topical Products to Catalyse the Growth of the Global Stretch Marks Treatment Industry

Based on treatment, the topical products segment is predicted to occupy a considerable share in the global stretch marks treatment industry during the forecast period. This growth can be attributed to the heightened utilisation of topical products in the treatment of stretch marks caused by pale skin, pregnancy, and sudden weight gain and loss, among others. In addition, the easy accessibility to topical products such as oils and serums also contributes to its popularity among consumers. Meanwhile, the laser segment is expected to contribute to the market growth owing to its non-invasive and quick treatment properties. For instance, in 2018, Candela Corporation announced the FDA approval for their Vbeam Prima, an advanced 595 nm pulsed dye laser (PDL), which is expected to help with many skin conditions such as acne, scars, benign pigmented lesions, and stretch marks. Therefore, these factors are estimated to drive the market growth in the forecast period.

 

North America to Possess a Significant Market Share in the Global Stretch Marks Treatment Industry

North America is predicted to possess a significant market share in the global stretch marks treatment industry. This can be attributed to the increased demand for stretch marks treatment in the region due to increased consciousness about cosmetics and fashion. In addition, the high disposable income and increased awareness of stretch marks treatment procedures are driving the market growth. Moreover, the growing rate of obesity in the region caused by the increasingly fat-laden diet is also a major factor in the growth of the industry. According to the 2020 statistics cited by Trust for America's Health, a non-profit organisation, adult obesity rate stands at 42.4%, which has increased by 26% since 2008. These factors are estimated to drive the market growth in the coming years.

 

Stretch Marks Treatment: Market Segmentation

Stretch marks, also known as striae, are off-coloured scars that appear in parallel bands on the body. These scars develop on the skin when it gets stretched and shrink quickly. The abrupt shrinking causes the collagen and elastin, which support our skin, to rupture, and as the skin heals, stretch marks appear. Moreover, an increase in the cortisone hormone, a hormone naturally produced by the adrenal glands, also causes stretch marks, as it reduces skin elasticity. These marks often affect the abdomen, buttocks, thighs, back, legs and breasts, among others. Abrupt weight gain and loss, pregnancy and puberty are some of the causes of stretch marks. In addition, stretch marks are not dangerous and can disappear over time. However, treatment may make them less noticeable more quickly.

 

Global Stretch Marks Treatment Market By End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By treatment, the market is distributed into:

  • Topical Products
  • Laser
  • Others

Among these, topical products can be segregated into oils and serum, creams, and lotions. While laser can be divided into fractional laser, pulse-dye laser, and others.

Based on end use, the market can be segmented into:

  • Hospitals and Clinics
  • Home Use

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Stretch Marks Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Consciousness Regarding Beauty and the Heightened Prevalence of Obesity to Augment the Growth of the Global Stretch Marks Treatment Industry

The increasing focus on beauty and wellness is one of the major factors driving the growth of the stretch marks treatment industry. In addition, the growing prevalence of obesity is expected to further aid the market growth. According to the WHO statistics, more than 1.9 billion adults, 18 years and older, were overweight in 2016. Of these, over 650 million were obese. Furthermore, in 2019, an estimated 38.2 million children under 5 years of age were overweight or obese. The cases of obesity are increasing in urban households caused by the imbalance between the consumed sum of calories and the number of calories expended. In addition, the growing popularity of fast food among the younger population is leading to an increased consumption of high fat and high sugar content. Moreover, the rise of a sedentary working environment with little physical activities, increasing urbanisation, and the changing modes of transportation are significantly contributing to the growing rates of obesity. Due to obesity, the excess fat leads to stretching of the skin, causing stretch marks. These factors are expected to drive the market growth in the forecast period.

 

Key Industry Players in the Global Stretch Marks Treatment market

The report gives a detailed analysis of the following key players in the global stretch marks treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Alliance Pharmaceuticals PLC
  • Clarins Group
  • Candela Corporation
  • Helix BioMedix, Inc.
  • HRA Pharma, SA
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment Type
  • Route of Administration
  • End User
  • Treatment Channel
  • Distribution Channel
  • Region
Breakup by Treatment Type
  • Topical Products
  • Lasers
  • Microdermabrasion
  • Others
Breakup by Route of Administration
  • Oral
  • Topical
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others
Breakup by Treatment Channel
  • Public
  • Private
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Clarins
  • Laboratoires Expanscience
  • Merz Pharma
  • Candela Corporation
  • Cynosure LLC
  • basq NYC
  • E.T. Browne Drug Co., Inc.
  • Lumenis Be Ltd.
  • Bio-Oil
  • Concord Medisys
  • Helix BioMedix, Inc.
  • The Boppy Company LLC
  • Cult Beauty
  • Casmara
  • Weleda
  • Mama Mio
  • Dermaclara
  • Strialite
  • Bayer AG
  • Helix BioMedix
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Stretch Marks Overview 

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Stretch Marks Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Stretch Marks Epidemiology (2016-2031)
    5.3    Europe Stretch Marks Epidemiology (2016-2031)
    5.4    Asia-Pacific Stretch Marks Epidemiology (2016-2031)
    5.5    Latin America Stretch Marks Epidemiology (2016-2031)
    5.6    Middle East & Africa Stretch Marks Epidemiology (2016-2031)
6    Global Stretch Marks Treatment Market Overview 
    6.1    Global Stretch Marks Treatment Market Historical Value (2017-2023) 
    6.2    Global Stretch Marks Treatment Market Forecast Value (2024-2032)
7    Global Stretch Marks Treatment Market Landscape
    7.1    Global Stretch Marks Treatment: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Global Stretch Marks Treatment Product Landscape
        7.2.1    Analysis by Treatment Type
        7.2.2    Analysis by Route of Administration
        7.2.3    Analysis by End User
8    Stretch Marks Treatment Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Stretch Marks Treatment Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Stretch Marks Treatment Market Segmentation
    11.1    Global Stretch Marks Treatment Market by Treatment Type
        11.1.1    Market Overview
        11.1.2    Topical Products
            11.1.2.1    Creams 
            11.1.2.2    Ointments
            11.1.2.3    Oils 
            11.1.2.4    Serums
            11.1.2.5    Lotions
        11.1.3    Lasers
            11.1.3.1    Fractional Laser
            11.1.3.2    Pulse-Dye Laser
            11.1.3.3    Others
        11.1.4    Microdermabrasion
        11.1.5    Others
    11.2    Global Stretch Marks Treatment Market by Route of Administration
        11.2.1    Market Overview
        11.2.2    Oral
        11.2.3    Topical
        11.2.4    Others
    11.3    Global Stretch Marks Treatment Market by End User
        11.3.1    Market Overview
        11.3.2    Hospitals
        11.3.3    Specialty Clinics
        11.3.4    Homecare
        11.3.5    Others
    11.4    Global Stretch Marks Treatment Market by Treatment Channel
        11.4.1    Market Overview
        11.4.2    Public
        11.4.3    Private
    11.5    Global Stretch Marks Treatment Market by Distribution Channel
        11.5.1    Market Overview
        11.5.2    Hospital Pharmacy
        11.5.3    Online Pharmacy
        11.5.4    Retail Pharmacy
    11.6    Global Stretch Marks Treatment Market by Region
        11.6.1    Market Overview
        11.6.2    North America
        11.6.3    Europe 
        11.6.4    Asia Pacific
        11.6.5    Latin America
        11.6.6    Middle East and Africa
12    North America Stretch Marks Treatment Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Stretch Marks Treatment Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Stretch Marks Treatment Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Stretch Marks Treatment Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Stretch Marks Treatment Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    Clarins
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Laboratoires Expanscience
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Merz Pharma
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Candela Corporation
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    Cynosure LLC
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    basq NYC
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    E.T. Browne Drug Co., Inc.
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Lumenis Be Ltd.
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    Bio-Oil
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Concord Medisys
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    Helix BioMedix, Inc.
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
    23.12    The Boppy Company LLC
        23.12.1    Financial Analysis
        23.12.2    Product Portfolio
        23.12.3    Demographic Reach and Achievements
        23.12.4    Mergers and Acquisitions
        23.12.5    Certifications
    23.13    Cult Beauty
        23.13.1    Financial Analysis
        23.13.2    Product Portfolio
        23.13.3    Demographic Reach and Achievements
        23.13.4    Mergers and Acquisitions
        23.13.5    Certifications
    23.14    Casmara
        23.14.1    Financial Analysis
        23.14.2    Product Portfolio
        23.14.3    Demographic Reach and Achievements
        23.14.4    Mergers and Acquisitions
        23.14.5    Certifications
    23.15    Weleda
        23.15.1    Financial Analysis
        23.15.2    Product Portfolio
        23.15.3    Demographic Reach and Achievements
        23.15.4    Mergers and Acquisitions
        23.15.5    Certifications
    23.16    Mama Mio
        23.16.1    Financial Analysis
        23.16.2    Product Portfolio
        23.16.3    Demographic Reach and Achievements
        23.16.4    Mergers and Acquisitions
        23.16.5    Certifications
    23.17    Dermaclara
        23.17.1    Financial Analysis
        23.17.2    Product Portfolio
        23.17.3    Demographic Reach and Achievements
        23.17.4    Mergers and Acquisitions
        23.17.5    Certifications
    23.18    Strialite
        23.18.1    Financial Analysis
        23.18.2    Product Portfolio
        23.18.3    Demographic Reach and Achievements
        23.18.4    Mergers and Acquisitions
        23.18.5    Certifications
    23.19    Bayer AG
        23.19.1    Financial Analysis
        23.19.2    Product Portfolio
        23.19.3    Demographic Reach and Achievements
        23.19.4    Mergers and Acquisitions
        23.19.5    Certifications
    23.20    Helix BioMedix
        23.20.1    Financial Analysis
        23.20.2    Product Portfolio
        23.20.3    Demographic Reach and Achievements
        23.20.4    Mergers and Acquisitions
        23.20.5    Certifications
24    Global Stretch Marks Treatment Market- Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global market for stretch marks treatment attained a value of USD 2.66 billion.

The market is anticipated to grow at a CAGR of 8.3% during the forecast period of 2024-2032 to reach a value of USD 5.46 billion by 2032.

The major drivers of the industry, such as the increased prevalence of stretch marks worldwide, rising awareness of stretch marks prevention and treatment procedures, rising urbanisation, growing disposable income, and increasing focus on aesthetics and beauty, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the heightened prevalence of obesity.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant treatments available in the market are topical products, laser, and others.

The significant end use segments include hospital and clinics and home use.

The major players in the industry are Alliance Pharmaceuticals PLC, Clarins Group, Candela Corporation, Helix BioMedix, Inc., and HRA Pharma, SA, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER